Gleason Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Gleason Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-55	Closed	-$48.3K	–	215
2023 Q4	$48.3K	Hold	55	–	–	0.01%	117
2023 Q3	$45.3K	Hold	55	–	–	0.01%	122
2023 Q2	$39.5K	Hold	55	–	–	0.01%	124
2023 Q1	$45.2K	Hold	55	–	–	0.01%	120
2022 Q4	$39.7K	Hold	55	–	–	0.01%	123
2022 Q3	$38K	Hold	55	–	–	0.01%	123
2022 Q2	$33K	Hold	55	–	–	0.01%	129
2022 Q1	$38K	Hold	55	–	–	0.01%	128
2021 Q4	$35K	Hold	55	–	–	0.01%	123
2021 Q3	$33K	Hold	55	–	–	0.01%	127
2021 Q2	$31K	Buy	+55	New	+$27.9K	0.01%	130

Other funds holding REGN

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return